Search results for "time factor"

showing 10 items of 3219 documents

Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.

2019

Essentials Prothrombotic extracellular vesicles (EV) carry agonist pathway-specific proteomes Agonists for protease activated receptor (PAR) 2 signaling have distinct effects on EV composition PAR2 signaling rapidly generates prothrombotic EV and slowly EV with inactive tissue factor (TF) FVIIa integrin ligation restricts TF incorporation into EV from endothelial cells SUMMARY: Background Cell injury signal-induced activation and release of tissue factor (TF) on extracellular vesicles (EVs) from immune and vessel wall cells propagate local and systemic coagulation initiation. TF trafficking and release on EVs occurs in concert with the release of cell adhesion receptors, including integrin …

Time Factorsmedia_common.quotation_subjectIntegrinFactor VIIa030204 cardiovascular system & hematologyThromboplastin03 medical and health sciencesTissue factorchemistry.chemical_compoundExtracellular Vesicles0302 clinical medicineHumansReceptor PAR-2Protease-activated receptorintegrin traffickingInternalizationReceptorCell adhesionBlood CoagulationCells Culturedmedia_commonbiologyFactor VIIChemistryIntegrin beta1protease-activated receptorsEndothelial CellsHematologytissue factorCell biologyProtein Transportbiology.proteinOligopeptidesIntracellularSignal TransductionJournal of thrombosis and haemostasis : JTH
researchProduct

Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protect…

1999

Transcutaneous immunization (TCI) using ligands of Toll-like receptors (TLRs) and cytotoxic T-lymphocyte (CTL) epitopes lead to the induction of potent T-cell responses. To characterize the efficacy of TCI-mediated CTL activation, we monitored the frequency and functional activity of specific CTL induced with TCI using the ovalbumin-derived epitope SIINFEKL composed in creme containing the synthetic TLR7 ligand R-837. We found that the frequency and activity decayed rapidly 10 d post-TCI. Consistently, no significant memory T-cell formation was detectable. In a prophylactic vaccination setting, TCI was protective against a lethal challenge with ovalbumin expressing EG.7 thymoma cells when t…

Time Factorsmedicine.drug_classT cellmedicine.medical_treatmentBiologyMonoclonal antibodyAdministration CutaneousLymphocyte ActivationEpitopeMiceAntigenCell Line TumorNeoplasmsmedicineImmunology and AllergyCytotoxic T cellAnimalsCD40 AntigensImiquimodGeneral MedicineImmunotherapyMice Inbred C57BLSurvival RateCTL*medicine.anatomical_structureImmunizationImmunologyAminoquinolinesImmunizationImmunotherapyImmunologic MemoryNeoplasm TransplantationT-Lymphocytes CytotoxicClinical reviews in allergyimmunology
researchProduct

Synthesis and cell surface display of class II determinants by long-term propagated rat T line cells

1987

We have investigated the capacity of the encephalitogenic BS rat T cell line bs 83 and its variant clone bs 83.III.C6 to synthesize and express RT1.B-specific class II molecule subsets defined by monoclonal antibodies (mAb) MRC-OX6 and MRC-OX3. Earlier studies had indicated that mAb MRC-OX6 recognizes three distinct molecular species: an immature oligomeric polypeptide chain complex comprised of the polymorphic subunits alpha, beta and the invariant proteins of the gamma group; a biosynthetic intermediate composed of post-translationally modified alpha, beta and gamma chain (denoted p35) and a fully glycosylated alpha, beta two-chain complex derived from the plasma membrane. MRC-OX3 was sho…

Time Factorsmedicine.drug_classT-LymphocytesT cellImmunologyAlpha (ethology)Cell SeparationBiologyMonoclonal antibodyEpitopeCell LineIodine RadioisotopesEpitopesAntigenmedicineAnimalsImmunology and AllergyBeta (finance)Polymorphism GeneticHistocompatibility Antigens Class IIMyelin Basic ProteinRats Inbred StrainsPrecipitin TestsRatsCell biologyPhenotypemedicine.anatomical_structureRats Inbred LewCell cultureMutationImmunologyImmunizationClone (B-cell biology)Immunoelectrophoresis Two-DimensionalEuropean Journal of Immunology
researchProduct

20 years of alveolar distraction : a systematic review of the literature

2018

Background The Vertical Alveolar Distraction Osteogenesis (VADO) technique is an excellent solution for bone and soft tissue neoformation in areas in which there has been significant bone atrophy that hinders normal rehabilitation using dental implants. The goal of this systematic review is to analyze the most relevant articles published on VADO in the literature over the past 20 years. Material and Methods The review was performed by using the keywords: “alveolar ridge”, “distraction ostegenesis” and “dental implant”. This search produced a total result of 240 articles. The clinical studies and cases reported in humans amounted to 113 articles, 18 articles referred to studies developed on …

Time Factorsmedicine.medical_treatment0206 medical engineeringOsteogenesis DistractionDentistryReview02 engineering and technology03 medical and health sciences0302 clinical medicineDistractionAlveolar ProcessAlveolar ridgemedicineHumansDental implantGeneral DentistrySurvival rateRehabilitationbusiness.industrySoft tissue030206 dentistry:CIENCIAS MÉDICAS [UNESCO]020601 biomedical engineeringNewcastle–Ottawa scaleOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASDistraction osteogenesisSurgeryOral Surgerybusiness
researchProduct

Increased resistance to oxidation of betalain-enriched human low density lipoproteins

2003

Betalains are natural pigments recently considered as compounds with potential antioxidative properties. In this work, ex vivo plasma spiking of pure either betanin or indicaxanthin, followed by isolation of low density lipoprotein (LDL), and measurement of its resistance to copper-induced oxidation, has been used to research if these betalains can bind to LDL and prevent oxidation of LDL lipids. When pooled human plasma from 10 healthy volunteers was incubated in the presence of 25-100 microM either betanin or indicaxanthin, incorporation of both compounds in LDL was observed, with a maximum binding of 0.52 +/- 0.08, and 0.51 +/- 0.06 nmoles of indicaxanthin and betanin, respectively, per …

Time Factorsmedicine.medical_treatmentBetalainsIndicaxanthinBiochemistryBetaninPyruAntioxidantsPyrusNatural antioxidantchemistry.chemical_compoundLipid oxidationQuaternary Ammonium CompoundBetalainmedicineHumansBetaninHuman LDLTime Factors.Dose-Response Relationship DrugVitamin ECarotenePrickly pearGeneral MedicineHydrogen PeroxideQuaternary Ammonium CompoundsLipoproteins LDLOxygenDose–response relationshipchemistryBiochemistryModels ChemicalLow-density lipoproteinlipids (amino acids peptides and proteins)AntioxidantBetalainIndicaxanthinHumanProtein Binding
researchProduct

Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial

2014

Background: The integrated treatment of first episode psychosis has been shown to improve functionality and negative symptoms in previous studies. In this paper, we describe a study of integrated treatment (individual psychoeducation complementary to pharmacotherapy) versus treatment as usual, comparing results at baseline with those at 6-month re-assessment (at the end of the study) for these patients, and online training of professionals to provide this complementary treatment, with the following objectives: 1) to compare the efficacy of individual psychoeducation as add-on treatment versus treatment as usual in improving psychotic and mood symptoms; 2) to compare adherence to medication,…

Time Factorsmedicine.medical_treatmentGlobal Assessment of FunctioningMedicine (miscellaneous)Liebowitz social anxiety scaleWeb-based instructionlaw.inventionStudy Protocolmulticenter trialClinical ProtocolsRandomized controlled triallawSurveys and QuestionnairesSingle-Blind MethodPharmacology (medical)PHARMACOLOGY (MEDICAL)validationPositive and Negative Syndrome ScaleCombined Modality TherapyTreatment OutcomeResearch Designspanish versionAprenentatge electrònicAnxietymedicine.symptomAntipsychotic Agentsmedicine.medical_specialtyPsicosiMedication Adherencescale1st-episode psychosisPredictive Value of TestsPsychoeducationmedicineHumansSocial BehaviorPsychiatryPsychiatric Status Rating ScalesInternetbusiness.industryMEDICINEBrain-Derived Neurotrophic FactorHamilton Rating Scale for DepressionPsychoses5-year follow-upstandard treatementPsychotherapyAffectLogistic ModelsMoodPsychotic Disordersopus trialSpainquality-of-lifeLinear ModelsQuality of Lifebusinesscognitive-behavior therapyBiomarkersComputer-Assisted InstructionTrials
researchProduct

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

1997

Abstract The current study was carried out to elucidate the immunoregulatory changes induced by venom immunotherapy (VIT) in bee or wasp allergic subjects. All subjects included in this study had a history of severe systemic allergic reactions to stings of the respective insect as well as positive skin tests with the respective venom or venom-specific IgE in the sera. Parameters assessed in peripheral blood mononuclear cells (PBMC) before and after initiation of VIT (rush therapy reaching a maintenance dose of 100 micrograms venom injected subcutaneously within 1 week) were expression of CD3, CD4, CD8, CD45RA, CD45RO, interleukin (IL)-2 receptor (R) alpha, IL-4R, IL-12R, Fc epsilon RII, CD4…

Time Factorsmedicine.medical_treatmentImmunologyCD40 LigandDown-RegulationVenomWasp VenomsImmunoglobulin ELigandsLymphocyte ActivationPeripheral blood mononuclear cellInterferon-gammaTh2 CellsAntigens CDT-Lymphocyte SubsetsmedicineImmunology and AllergyHumansLymphocyte CountRNA MessengerCD40 AntigensCD40Membrane GlycoproteinsbiologyReceptors IgEInterleukinAntibodies MonoclonalInsect Bites and StingsReceptors InterleukinAllergensTh1 CellsInterleukin-10Receptors Interleukin-4Interleukin 10Bee VenomsCytokineDesensitization ImmunologicImmunologyAntigens Surfacebiology.proteinInterleukin-4AntibodyEuropean journal of immunology
researchProduct

Analysing the Spanish smoke-free legislation of 2006: a new method to quantify its impact using a dynamic model.

2011

Background: There are many models that study aspects of smoking habits: the influence of price, tax, relapse time, and the effects of prohibition. There are also studies examining the effects of the Spanish smoke-free law. We wanted to build a model able to separate the effect of the law from the pre-law evolution of smoking habits. Methods: Using data from the Spanish Ministry of Health and Social Policy, we developed a dynamic model of tobacco use. The model projects the evolution over time of the number of non-smokers, smokers and ex-smokers before 2006. Then, we compared the predictions of the model with data for the years after the law came into force, 2006 and 2009. Results: We show t…

Time Factorsmedicine.medical_treatmentMedicine (miscellaneous)Smoking PreventionSmoking cessationHealth policy evaluationMathematical modelRecurrencePrevalenceSecondary PreventionSmoking habitWorkplaceSmoke free legislationhealth care economics and organizationsmedia_commonSocial policyPriority journalPublic healthHealth PolicySmokingTobacco Use DisorderMiddle AgedTobacco smokingPolicybehavior and behavior mechanismsMATEMATICA APLICADASimulationHumanAdultmedicine.medical_specialtyAdolescentmedia_common.quotation_subjectHealth PromotionModels PsychologicalArticleSmoke free legislationYoung AdultEnvironmental healthmedicineHumansComputer SimulationHealth policyAgedbusiness.industryPublic healthGovernment regulationWork (physics)Health Surveysrespiratory tract diseasesHealth promotionSpainSmoking cessationSimulation modelSmoking CessationTobacco Smoke PollutionHabitbusinessPredictionControlled studyLawDemographyThe International journal on drug policy
researchProduct

Prostaglandin E(2)-loaded microspheres as strategy to inhibit phagocytosis and modulate inflammatory mediators release.

2008

PGE(2), an arachidonic acid metabolite produced by various type of cells regulates a broad range of physiological activities in the endocrine, cardiovascular, gastrointestinal, and immune systems, and is involved in maintaining the local homeostasis. In the immune system, PGE(2) is mainly produced by APCs and it can suppress the Th1-mediated immune responses. The aim of this study was to develop PGE(2)-loaded biodegradable MS that prolong and sustain the in vivo release of this mediator. An o/w emulsion solvent extraction-evaporation method was chosen to prepare the MS. We determined their diameters, evaluated the in vitro release of PGE(2), using enzyme immunoassay and MS uptake by periton…

Time Factorsmedicine.medical_treatmentPhagocytosisChemistry PharmaceuticalDrug CompoundingPharmaceutical ScienceInflammationPharmacologyBiologyNitric OxideDinoprostonechemistry.chemical_compoundMiceImmune systemPhagocytosisIn vivoSepsismedicineAnimalsHumansImmunologic FactorsProstaglandin E2Particle SizeCells CulturedChemokine CCL2Tumor Necrosis Factor-alphaEndothelial CellsWaterGeneral MedicineMicrospheresDisease Models AnimalchemistryBiochemistrySolubilityDelayed-Action PreparationsMacrophages PeritonealLiberationlipids (amino acids peptides and proteins)Arachidonic acidEmulsionsmedicine.symptomInflammation MediatorsOilsBiotechnologyProstaglandin Emedicine.drugEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo

2005

Deregulation of apoptosis signalling is commonly found in cancer and results in resistance to cytotoxic therapies. Immunotherapy is a promising strategy to eliminate resistant cancer cells. The transfer of T-lymphocytes during allogeneic stem cell transplantation is clinically explored to induce a 'graft-versus-tumor' effect (GvT). Cytotoxic T-lymphocytes (CTL), which are major effectors of GvT, eliminate cancer cells by inducing apoptosis via multiple parallel pathways. Here, we study in vitro and in vivo the susceptibility of murine cancer cells engineered to express single antiapoptotic genes to CTL-mediated cytotoxicity. Interestingly, we find that single inhibitors of caspase activatio…

Time Factorsmedicine.medical_treatmentbcl-X ProteinApoptosisMice TransgenicMiceHLA-A2 AntigenTumor Cells CulturedmedicineAnimalsCytotoxic T cellFADDMolecular BiologybiologyCancerCell BiologyImmunotherapymedicine.diseaseAdoptive TransferMitochondriaEnzyme ActivationTransplantationCTL*Proto-Oncogene Proteins c-bcl-2CaspasesCancer cellImmunologybiology.proteinCancer researchTumor Suppressor Protein p53Stem cellT-Lymphocytes CytotoxicCell Death & Differentiation
researchProduct